June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
CLINICAL VALIDATION OF CONTRAST SENSITIVITY MEASURED BY VISUAL SIMULATION FOR PSEUDOPHAKIC PATIENTS
Author Affiliations & Notes
  • Silvestre Manzanera
    Laboratorio de Optica, Universidad de Murcia, Murcia, Spain
  • Aixa Alarcon
    AMO, Groningen, Netherlands
  • Carmen Canovas
    AMO, Groningen, Netherlands
  • Pedro M. Prieto
    Laboratorio de Optica, Universidad de Murcia, Murcia, Spain
  • Linda Tsai
    AMO, Santa Ana, CA
  • Kendra Hileman
    AMO, Santa Ana, CA
  • Patricia A Piers
    AMO, Groningen, Netherlands
  • Pablo Artal
    Laboratorio de Optica, Universidad de Murcia, Murcia, Spain
  • Footnotes
    Commercial Relationships Silvestre Manzanera, Abbott Medical Optics (F); Aixa Alarcon, Abbott Medical Optics (E); Carmen Canovas, Abbott Medical Optics (E); Pedro Prieto, Abbott Medical Optics (F); Linda Tsai, Abbott Medical Optics (E); Kendra Hileman, Abbott Medical Optics (E); Patricia Piers, Abbott Medical Optics (E); Pablo Artal, Abbott Medical Optics (C), Abbott Medical Optics (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3571. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Silvestre Manzanera, Aixa Alarcon, Carmen Canovas, Pedro M. Prieto, Linda Tsai, Kendra Hileman, Patricia A Piers, Pablo Artal; CLINICAL VALIDATION OF CONTRAST SENSITIVITY MEASURED BY VISUAL SIMULATION FOR PSEUDOPHAKIC PATIENTS. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3571.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Adaptive optics (AO) vision simulation predicts high-contrast binocular visual acuity following cataract surgery for different IOL designs well (Schwarz, ARVO 2014). The purpose of this study is to compare the clinical contrast sensitivity (CS) measured in patients implanted with different IOL models to those predicted by AO visual simulation for the phase profiles of the same IOLs.

Methods: Phase profiles corresponding to five different IOLs (two monofocal IOLs, one aspheric and one spherical, and three diffractive multifocal IOLs) were generated bilaterally in a binocular AO visual simulator. CS was measured in 5 subjects for a 4.5 mm pupil in white light under mesopic conditions using the quick-CSF procedure. In all cases, natural astigmatism and spherical aberration were corrected. The measured CS was compared to the clinical outcomes measured independently in two different clinical trials in pseudophakic patients bilaterally implanted with the same IOL models. In these clinical trials, mesopic CS was measured without glare at 1.5, 3, 6 and 12 c/deg with either a Vector Vision or an Optec 6500 chart. Measurements were performed at 6 months postoperatively with best distance correction in place, according to common clinical practice.

Results: CS measured in clinical studies was correlated with CS measured in the AO instrument for the IOL models evaluated (r^2=0.73). This correlation was higher for the lower and higher spatial frequencies than for middle spatial frequencies. When considering different IOL models independently, the correlation between clinical and simulated CS decreased (r^2=0.49) for the monofocal IOL design that corrects for spherical aberration, while the remaining models provided correlated well (r^2>0.8 for all models).

Conclusions: AO visual simulation predicts clinical CS following cataract surgery under binocular conditions for refractive and diffractive IOL designs. The correlation was better for high and low spatial frequencies and for multifocal and monofocal spherical designs. These results validate the use of AO instruments as a tool for developing new IOL optics and their impact on the quality of vision.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×